SIM
ACHN

Spark Investment Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Spark Investment Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-645,400
Closed -$1.03M – 769
2018
Q4 		$1.03M Buy
645,400
+579,900
+885% +$1.64M 0.07% 313
2018
Q3 		$241K Sell
65,500
-130,400
-67% -$389K 0.01% 544
2018
Q2 		$554K Buy
195,900
+95,600
+95% +$326K 0.03% 431
2018
Q1 		$372K Sell
100,300
-600,700
-86% -$1.97M 0.02% 433
2017
Q4 		$2.02M Buy
701,000
+422,800
+152% +$1.54M 0.11% 260
2017
Q3 		$1.25M Buy
278,200
+82,400
+42% +$366K 0.07% 346
2017
Q2 		$898K Sell
195,800
-514,300
-72% -$2.07M 0.06% 410
2017
Q1 		$2.99M Sell
710,100
-268,500
-27% -$1.11M 0.19% 174
2016
Q4 		$4.04M Buy
978,600
+892,600
+1,038% +$4.74M 0.33% 73
2016
Q3 		$696K Sell
86,000
-103,400
-55% -$879K 0.06% 417
2016
Q2 		$1.48M Buy
189,400
+73,900
+64% +$634K 0.14% 241
2016
Q1 		$891K Buy
+115,500
New +$846K 0.09% 321

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Spark Investment Management's ACHN Position: Q1 2019 in Review

Spark Investment Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2019, closing a stake of 645,400 shares — an estimated $1.03M sold.

Spark Investment Management first reported a position in ACHN in Q1 2016 and held it in 12 quarters. The position peaked at $4.04M in Q4 2016. 110 funds tracked by Wall St. Rank hold ACHN as of Q1 2019.

  • Spark Investment Management reported no remaining Achillion Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Spark Investment Management sold 645,400 Achillion Pharmaceuticals shares in Q1 2019, an estimated $1.03M.
  • Spark Investment Management first reported a position in Achillion Pharmaceuticals in Q1 2016 and held it in 12 quarters.
  • Spark Investment Management's Achillion Pharmaceuticals position peaked at $4.04M in Q4 2016.
  • 110 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2019.

Based on Spark Investment Management's 13F filing for Q1 2019, filed 7 May 2019.